Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Metadata
Title
Current and developing chemotherapy for CLL
Author
Emili Montserrat
Publication date
01-06-2002
Publisher
Humana Press
Published in
Medical Oncology / Issue Special Issue 2/2002
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:19:2S:S11

Other articles of this Special Issue 2/2002

Medical Oncology 2/2002 Go to the issue

Original Article

Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia

Original Article

Future prospects for alemtuzumab (MabCampath™)

Original Article

A personal history of the CAMPATH-1H antibody

Original Article

Alemtuzumab in T-cell malignancies

Original Article

Alemtuzumab in stem cell transplantation

EditorialNotes

Guest editorial

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits